Cognoa is developing digital products intended to support healthcare providers in expediting diagnosis with the goal of improving access to timely intervention for children and families, starting with autism spectrum disorder (ASD).

We are developing digital diagnostic and therapeutic products with the goal of enabling earlier and more equitable care for behavioral health conditions.

Hazel partners with schools and families to provide physical and mental health care that helps students feel better and get back to learning.

Cognoa seeks to help improve the lives and outcomes of children and their families living with behavioral health conditions. We strive to improve timely, equitable access to a diagnosis for caregivers with early concerns of developmental delay, including autism, to support opportunities for early intervention and improved outcomes for children and their families.

We started Hazel to fill critical gaps in pediatric health care—to build a new model of care that meets the needs of every family and child.

Our founders saw that many families and children, especially in underserved communities, struggle to access care. Barriers including lengthy waitlists, missed hours of school and work, transportation, and costly emergency care limit access to health care, which affects students' academic performance, attendance, and general well-being.

Since 2015, we’ve been partnering with school districts to bring health care to children where they spend the majority of their time–school.